Hypertension Diagnostics, Inc. Newsroom


	Hypertension Diagnostics to Demonstrate CVProfilor^® System at the ACP-ASIM Annual Conference ST. PAUL, MN – April 4, 2002 – Hypertension Diagnostics, Inc. (NASDAQ SmallCap: HDII), announced today that it plans to exhibit at the American College of Physicians – American Society of Internal Medicine (ACP-ASIM) Annual Session in Philadelphia, Pennsylvania, April 11-14, 2002. The ACP-ASIM Annual Session is internal medicine’s pre-eminent educational and networking event anticipated to attract over 5,000 physicians and other health professionals representing the entire spectrum of internal medicine.
	Greg H. Guettler, President of Hypertension Diagnostics said, “Health promotion and disease prevention is a key area of specialty for internists. We are looking forward to introducing our CVProfilor^® DO-2020 technology to physicians and other health care professionals at this meeting by offering personal CVProfile™ tests. The CVProfilor^® System provides a means to assess the early arterial changes by providing measurements of both large and small artery elasticity – which are useful in disease prevention and management.” Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology. Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2001 Annual Report on Form 10-KSB under the caption “Risk Factors,” as well as others not now anticipated. CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Investor Relations: Jens Dalsgaard and Tony Altavilla, Managing Directors Redwood Consultants, LLC Mill Valley, CA 94941 415-380-0500 Contact: Greg H. Guettler, President Return to the Main HDI Newsroom Back to Top

Copyright © 2009 Hypertension Diagnostics, Inc Last revised Wednesday February 11, 2009 HDI Legal Information